Future directions of postoperative spinal implant infections.

This article outlines some promising future concepts against postoperative spinal implant infections on the basis of today available literature. The ever-adapting bacteria causing this common complication compel a corresponding continuous research about best effective treatment. The aim is to give a perspective on several future attack-points: surgical infection prevention strategies such as technical optimization of implants and surgical technique; faster diagnostic tools to detect infection, especially in the context of late infections with low-virulent germs and with regard to decision-making in the course of the surgical workflow; and combined surgical and medical treatment options against implant infections. The surgical treatment section will also state open issues concerning implant removal, and the medical treatment section will give an outlook to promising medical alternatives in a post-antibiotic era. To keep up in this field will be important to retain spine surgery in the future as the state-of-the-art treatment option for mandatory spinal interventions in the presence of tumor or trauma and even more so as an attractive option for patients with degenerative spinal disorder for improvement of their life quality.

[1]  Lauren N. Pearson,et al.  Letter to the Editor on "The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria". , 2020, The Journal of arthroplasty.

[2]  V. Goel,et al.  A Multicenter Trial Demonstrating Presence or Absence of Bacterial Contamination at the Screw-Bone Interface Owing to Absence or Presence of Pedicle Screw Guard, Respectively, During Spinal Fusion , 2020, Clinical spine surgery.

[3]  Jeffrey C. Wang,et al.  Updates on Evidence-Based Practices to Reduce Preoperative and Intraoperative Contamination of Implants in Spine Surgery: A Narrative Review , 2019, Spine surgery and related research.

[4]  Samuel K. Cho,et al.  Biomaterials in Spinal Implants: A Review , 2019, Neurospine.

[5]  P. Severi,et al.  Infection with Spinal Instrumentation: A 20-Year, Single-Institution Experience with Review of Pathogenesis, Diagnosis, Prevention, and Management , 2019, Asian journal of neurosurgery.

[6]  C. Perka,et al.  Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa , 2019, Antimicrobial Agents and Chemotherapy.

[7]  L. Domachevsky,et al.  The Role of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in the Diagnosis of Postoperative Hardware-Related Spinal Infections. , 2019, The Israel Medical Association journal : IMAJ.

[8]  P. Vajkoczy,et al.  High frequency of low-virulent microorganisms detected by sonication of pedicle screws: a potential cause for implant failure. , 2019, Journal of neurosurgery. Spine.

[9]  Jeffrey C. Wang,et al.  Harboring Contaminants in Repeatedly Reprocessed Pedicle Screws , 2018, Global spine journal.

[10]  Jun S. Kim,et al.  Postoperative Spine Infection: Diagnosis and Management , 2018, Global spine journal.

[11]  Antonia F. Chen,et al.  What Markers Best Guide the Timing of Reimplantation in Two-stage Exchange Arthroplasty for PJI? A Systematic Review and Meta-analysis , 2018, Clinical orthopaedics and related research.

[12]  A. Leithner,et al.  Pedicle screw loosening is correlated to chronic subclinical deep implant infection: a retrospective database analysis , 2018, European Spine Journal.

[13]  J. Parvizi,et al.  The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. , 2018, The Journal of arthroplasty.

[14]  S. Shivaswamy,et al.  A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia , 2018, PloS one.

[15]  H. Abdelbary,et al.  Current review—The rise of bacteriophage as a unique therapeutic platform in treating peri‐prosthetic joint infections , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[16]  R. G. Richards,et al.  Infection after fracture fixation: Current surgical and microbiological concepts. , 2016, Injury.

[17]  Asad U. Khan,et al.  Nano-therapeutics: A revolution in infection control in post antibiotic era. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[18]  A. Benditz,et al.  Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study , 2017, Drug design, development and therapy.

[19]  D. Monti,et al.  Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  P. Kubes,et al.  Br Ief Definitive Repor T Identification and Treatment of the Staphylococcus Aureus Reservoir in Vivo , 2022 .

[21]  Alan H. Daniels,et al.  Antimicrobial technology in orthopedic and spinal implants. , 2016, World journal of orthopedics.

[22]  Lorena Rodríguez-Rubio,et al.  Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry , 2016, Front. Microbiol..

[23]  Q. Guo,et al.  Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice , 2016, PloS one.

[24]  Y. Carmeli,et al.  Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis. , 2016, The Journal of antimicrobial chemotherapy.

[25]  M. Rybak,et al.  Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections , 2016, Infectious Diseases and Therapy.

[26]  Nicole R. Luke-Marshall,et al.  Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model , 2016, Clinical orthopaedics and related research.

[27]  G. Nath,et al.  Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model , 2016, The Indian journal of medical research.

[28]  P. S. Andersen,et al.  Novel antibody–antibiotic conjugate eliminates intracellular S. aureus , 2015, Nature.

[29]  Peter C. Fineran,et al.  A century of the phage: past, present and future , 2015, Nature Reviews Microbiology.

[30]  D. Lehoux,et al.  Oritavancin Pharmacokinetics and Bone Penetration in Rabbits , 2015, Antimicrobial Agents and Chemotherapy.

[31]  R. Hancock,et al.  D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. , 2015, Chemistry & biology.

[32]  Nicole R. Luke-Marshall,et al.  Cathodic voltage-controlled electrical stimulation of titanium implants as treatment for methicillin-resistant Staphylococcus aureus periprosthetic infections. , 2015, Biomaterials.

[33]  J. Baldassarre,et al.  Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue , 2015, Antimicrobial Agents and Chemotherapy.

[34]  A. Bahar,et al.  Antimicrobial Peptides , 2013, Pharmaceuticals.

[35]  Lee A. Tan,et al.  Infection with spinal instrumentation: Review of pathogenesis, diagnosis, prevention, and management , 2013, Surgical neurology international.

[36]  A. Quaile Infections associated with spinal implants , 2012, International Orthopaedics.

[37]  I. Sia,et al.  Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[38]  Eve Neesham-Grenon,et al.  Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro , 2008, Antimicrobial Agents and Chemotherapy.

[39]  C. Van de Wiele,et al.  18-Fluorine Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Infection in the Postoperative Spine , 2003, Spine.

[40]  P E Ochsner,et al.  Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.

[41]  D. Raoult,et al.  Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. , 1997, The Journal of antimicrobial chemotherapy.

[42]  A. Widmer,et al.  Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. , 1994, The Journal of antimicrobial chemotherapy.

[43]  S. Kunz,et al.  Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin , 1992, Antimicrobial Agents and Chemotherapy.